Clinical Trials in the Netherlands / NCT06641362
Recruiting Observational

Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)

NCT06641362 · tracked via the Priya Life Science Netherlands tracker
Sponsor
VDI Technologies
Phase
Observational
Started
2025-03-18
Last updated
2026-05-05

Condition(s) studied

BradycardiaHeart FailureVentricular Dysfunction

Investigational drug(s) / intervention(s)

Ultra High Frequency Electrocardiogram (UHF-ECG)

Ultra High Frequency Electrocardiogram (UHF-ECG): Electrocardiograms used on participants scheduled to undergo pacemaker implantation for bradycardia and/or heart failure.

Study summary

The purpose of this study is to demonstrate the safety and effectiveness of the VDI UHF-ECG System in the diagnosis of ventricular dyssynchrony when compared to the 12-lead ECG in patients with bradycardia and heart failure indicated for pacemaker implantation.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adults with bradycardia or heart failure scheduled for first time pacemaker implant (including CRT/CSP) with one of the following: Bradycardia with ventricular synchrony and QRS duration \<= 110 ms, Bradycardia with LBBB, Bradycardia with RBBB, Bradycardia with other IVCD necessitating intervention, or Heart failure with LBBB * Understands the nature of the study and is willing to comply with all study requirements. * Provides written informed consent. * A negative pregnancy test prior to the procedure for participants of child-bearing potential. Exclusion Criteria: * Complete AV block (3rd-degree AV block) without a stable escape rhythm or other circumstances where there is no measurable QRS. * Subjects with a previous or current pacemaker or defibrillator implant. * Anatomical or other conditions that may make a 12-lead ECG difficult to obtain, such as an allergy to components of the ECG pads, burns, open wounds, etc. * Currently enrolled in another investigational device or drug trial that has not completed the active treatment phase and/or would conflict with this study. * Other co-morbid condition(s) that could limit the participant's ability to participate in the study or to comply with study requirements or impact the scientific integrity of the study.

Primary outcome measure(s)

Trial sites (12)

FacilityCityRegionStatus
Peak Heart and Vascular Avondale Arizona Recruiting
Banner Medical Center Mesa Arizona Recruiting
University of Chicago Chicago Illinois Recruiting
Mayo Clinic Rochester Minnesota Recruiting
Ohio State University Columbus Ohio Recruiting
Baylor College of Medicine Houston Texas Recruiting
University of Virginia Charlottesville Virginia Recruiting
Fakultní nemocnice Brno Brno Czechia Recruiting
St. Anne's University Hospital Brno Czechia Recruiting
Na Homolce Hospital Prague Czechia Recruiting
Fakultni Nemocnice Královské Vinohrady Prague Czechia Recruiting
Catherina Ziekenhuis Eindhoven Netherlands Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06641362 on ClinicalTrials.gov ↗ ← All trials in the Netherlands